Jaron R, Rosenfeld N, Zahdeh F, Carmi S, Beni-Adani L, Doviner V, Picard E, Segel R, Zeligson S, Carmel L, Renbaum P, Levy-Lahad E
Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Faculty of Medicine, The Hebrew University of Jerusalem Medical School, Jerusalem, Israel.
Clin Genet. 2016 Dec;90(6):540-544. doi: 10.1111/cge.12764. Epub 2016 May 2.
Recessive CRB2 mutations were recently reported to cause both steroid resistant nephrotic syndrome and prenatal onset ventriculomegaly with kidney disease. We report two Ashkenazi Jewish siblings clinically diagnosed with ciliopathy. Both presented with severe congenital hydrocephalus and mild urinary tract anomalies. One affected sibling also has lung hypoplasia and heart defects. Exome sequencing and further CRB2 analysis revealed that both siblings are compound heterozygotes for CRB2 mutations p.N800K and p.Gly1036Alafs*43, and heterozygous for a deleterious splice variant in the ciliopathy gene TTCB21. CRB2 is a polarity protein which plays a role in ciliogenesis and ciliary function. Biallelic CRB2 mutations in animal models result in phenotypes consistent with ciliopathy. This report expands the phenotype of CRB2 mutations to include lung hypoplasia and uretero-pelvic renal anomalies, and confirms cardiac malformation as a feature. We suggest that CRB2-associated disease is a new ciliopathy syndrome with possible digenic/triallelic inheritance, as observed in other ciliopathies. Clinically, CRB2 should be assessed when ciliopathy is suspected, especially in Ashkenazi Jews, where we found that p.N800K carrier frequency is 1 of 64. Patients harboring CRB2 mutations should be tested for the complete range of ciliopathy manifestations.
最近有报道称,隐性CRB2突变可导致类固醇抵抗性肾病综合征以及伴有肾脏疾病的产前脑室扩大。我们报告了两名临床诊断为纤毛病的阿什肯纳兹犹太裔同胞。两人均患有严重的先天性脑积水和轻度泌尿系统异常。其中一名患病同胞还患有肺发育不全和心脏缺陷。外显子组测序及进一步的CRB2分析显示,两名同胞均为CRB2突变p.N800K和p.Gly1036Alafs*43的复合杂合子,并且在纤毛病基因TTCB21中存在有害剪接变异的杂合子。CRB2是一种极性蛋白,在纤毛发生和纤毛功能中发挥作用。动物模型中的双等位基因CRB2突变会导致与纤毛病一致的表型。本报告将CRB2突变的表型扩展至包括肺发育不全和输尿管肾盂肾异常,并确认心脏畸形是其特征之一。我们认为,CRB2相关疾病是一种新的纤毛病综合征,可能存在双基因/三基因遗传,正如在其他纤毛病中所观察到的那样。临床上,当怀疑为纤毛病时,应评估CRB2,尤其是在阿什肯纳兹犹太人中,我们发现p.N800K携带者频率为64分之一。携带CRB2突变的患者应接受全面的纤毛病表现检测。